Patent: 9,562,904
✉ Email this page to a colleague
Summary for Patent: 9,562,904
Title: | Competition based-detection assays |
Abstract: | Disclosed herein are methods and kits which are useful for detecting presence of an enzyme and the relative amount of glycan associated with the enzyme in a test sample based upon the enzyme\'s ability to competitively inhibit the binding of a ligand in such test sample. The present invention provides the ability to evaluate cell culture conditions and optimize the desired glycoform content of recombinantly prepared enzymes. |
Inventor(s): | Roseman; Daniel S. (Framingham, MA) |
Assignee: | Shire Human Genetic Therapies, Inc. (Lexington, MA) |
Application Number: | 14/729,498 |
Patent Claims: | see list of patent claims |
Details for Patent 9,562,904
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Takeda Pharmaceuticals U.s.a., Inc. | ELAPRASE | idursulfase | Injection | 125151 | 07/24/2006 | ⤷ Try a Trial | 2031-06-08 |
Aimmune Therapeutics, Inc. | PALFORZIA | peanut (arachis hypogaea) allergen powder | Powder | 125696 | 01/31/2020 | ⤷ Try a Trial | 2031-06-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |